Roquefort Therapeutics (ROQ) Insider Trading & Ownership GBX 1.66 -0.01 (-0.60%) As of 03/28/2025 12:36 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock Roquefort Therapeutics (LON:ROQ) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage60.40%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)£12,000.00Number OfInsiders Selling(Last 12 Months)0 Get ROQ Insider Trade Alerts Want to know when executives and insiders are buying or selling Roquefort Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ROQ Insider Buying and Selling by Quarter Remove Ads Roquefort Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/4/2025Stephen Paul WestInsiderBuy400,000GBX 3£12,000 (Data available from 1/1/2013 forward) ROQ Insider Trading Activity - Frequently Asked Questions Who is on Roquefort Therapeutics's Insider Roster? The list of insiders at Roquefort Therapeutics includes Dr Darrin Disley, Stephen Paul West, and Trevor Ajanthan (Ajan) Reginald. Learn more on insiders at ROQ. What percentage of Roquefort Therapeutics stock is owned by insiders? 60.40% of Roquefort Therapeutics stock is owned by insiders. Learn more on ROQ's insider holdings. Which Roquefort Therapeutics insiders have been buying company stock? The following insiders have purchased ROQ shares in the last 24 months: Dr Darrin Disley (£18,895.45), Stephen Paul West (£23,031.99), and Trevor Ajanthan (Ajan) Reginald (£2,468.55). How much insider buying is happening at Roquefort Therapeutics? Insiders have purchased a total of 865,047 ROQ shares in the last 24 months for a total of £44,395.99 bought. Roquefort Therapeutics Key ExecutivesMr. Stephen Paul West B.Com (Age 52)CA, Executive Chairman Compensation: $152.9k1 recent tradesMr. Trevor Ajanthan Reginald (Age 52)CEO & Executive Director Compensation: $305.8kProf. Martin J. Evans FRS (Age 83)Group Chief Scientific Officer & Executive Director Compensation: $100kDr. Emma MorrisHead of Pre-Clinical Research More Insider Trading Tools from MarketBeat Related Companies OBD Insider Trades IXI Insider Trades FAB Insider Trades DEST Insider Trades ONC Insider Trades OCTP Insider Trades GNS Insider Trades ONT Insider Trades OXB Insider Trades 4BB Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (LON:ROQ) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | SponsoredTrump… a socialist? Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roquefort Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Roquefort Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ROQ Stock Free ROQ Stock Alerts